STOCK TITAN

Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

Tharimmune (NASDAQ:THAR) will rebrand as Canton Strategic Holdings, Inc. and begin trading under ticker CNTN on February 18, 2026. The company pursues a digital asset treasury strategy after a $545 million private placement and a $55 million registered offering to fund Canton Coin, Super Validator operations, and ecosystem investments.

Key milestones include Super Validator approval, board additions, and commitment to quarterly ecosystem reporting to support institutional Canton Network adoption.

Loading...
Loading translation...

Positive

  • Private placement raised $545 million (Nov 2025)
  • Closed $55 million underwritten registered offering
  • Approved to operate as a Super Validator
  • NASDAQ ticker change to CNTN effective Feb 18, 2026
  • Board additions of Jill Sommers and William Wiley

Negative

  • None.

Key Figures

Private placement size: $545 million Registered offering: $55 million Canton Network volume: $9 trillion +5 more
8 metrics
Private placement size $545 million Established digital asset treasury strategy in November 2025
Registered offering $55 million Underwritten registered offering closed Jan 22, 2026
Canton Network volume $9 trillion Monthly transaction volume processed on Canton Network
Canton transactions 700,000+ daily transactions Supported by Super Validators on Canton Network
Shelf capacity $2,000,000,000 Maximum aggregate amount under S-3 shelf registration
ATM program size $64,910,161 At-the-market offering capacity for common stock
Shares outstanding 37,386,114 shares Common shares outstanding as of Jan 6, 2026
Broadridge warrants 4,187,548 shares Shares underlying warrants counted in 9.99% stake

Market Reality Check

Price: $4.48 Vol: Volume 469,586 vs 20-day ...
low vol
$4.48 Last Close
Volume Volume 469,586 vs 20-day average 1,485,030 (relative volume 0.32x), indicating subdued trading ahead of the rebrand. low
Technical Price at $4.48, trading above 200-day MA of $2.60, reflecting an uptrend into the rebranding announcement.

Peers on Argus

THAR was up 4.67% while biotech peers were mixed: MTVA -10.14%, BLRX -3.3%, EDSA...
3 Up

THAR was up 4.67% while biotech peers were mixed: MTVA -10.14%, BLRX -3.3%, EDSA +3.03%, LPCN -1.25%, SYBX -0.79%. Momentum scanner showed EDSA, NBY, and BLRX all up, without related news, suggesting THAR’s move was stock-specific rather than a coordinated sector move.

Historical Context

5 past events · Latest: Feb 06 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Feb 06 Leadership changes Positive +5.3% New Chairman and COO appointments reinforcing Canton Network-focused strategy.
Feb 05 Earnings (peer) Positive -16.9% Tradeweb strong 4Q25 revenue and income tied partly to Canton Coin gains.
Feb 02 Board refresh Positive +12.1% Election of two directors with regulatory and capital‑markets expertise.
Jan 26 Super Validator role Positive +9.1% Approval to operate as Super Validator and publish quarterly ecosystem research.
Jan 22 Equity offering Neutral +7.9% Closing of $55M underwritten registered offering to fund Canton-centric strategy.
Pattern Detected

Recent Tharimmune news tied to the Canton Network strategy has generally been followed by positive price reactions, including governance, validator, and financing updates, with only an external peer’s earnings showing a negative move.

Recent Company History

Over the last month, Tharimmune has repeatedly advanced its Canton-centric digital asset treasury strategy. On Jan 22, it closed a $55M underwritten registered offering to fund this strategy. On Jan 26, it announced Super Validator approval on the Canton Network, pointing to >700,000 daily transactions and $9T in monthly volume. New independent directors were elected on Jan 30, and leadership changes, including a new COO and Chairman, were disclosed in early February. These steps frame today’s rebrand and ticker change as a continuation of that strategic pivot.

Regulatory & Risk Context

Active S-3 Shelf · $2,000,000,000
Shelf Active
Active S-3 Shelf Registration 2026-01-09
$2,000,000,000 registered capacity

An effective S-3 shelf filed on 2026-01-09 permits Tharimmune to issue up to $2,000,000,000 of various securities over time, with proceeds generally earmarked for its digital asset treasury strategy, product development, and corporate purposes. The company has already used this shelf once via a 424B5 prospectus on 2026-01-20, indicating capacity for additional capital raises.

Market Pulse Summary

This announcement formalizes Tharimmune’s evolution into Canton Strategic Holdings, aligning its ide...
Analysis

This announcement formalizes Tharimmune’s evolution into Canton Strategic Holdings, aligning its identity with a Canton Network-focused digital asset treasury strategy. The company previously raised $545M in a private placement and $55M in an underwritten offering, secured Super Validator status, and expanded its board with capital-markets experts. Investors may watch how the rebrand, ticker change, and use of an effective $2,000,000,000 shelf and ATM program translate into ecosystem growth and shareholder value over time.

Key Terms

private placement, super validator, underwritten registered offering
3 terms
private placement financial
"Established in November 2025 through a $545 million private placement, the Company executes"
A private placement is a way for companies to raise money by selling securities directly to a small group of investors instead of through a public offering. This process is often quicker and less regulated, making it similar to offering a special, exclusive investment opportunity to select individuals or institutions. For investors, it can provide access to unique investment options that are not available on public markets.
super validator technical
"including Canton Coin acquisition, operation of a Super Validator, and continued investment"
A super validator is an entity or operator in a proof‑of‑stake cryptocurrency network that has been selected or earned the right to check and confirm transactions and create new blocks more often than ordinary validators. Think of it like a trusted traffic controller for a digital ledger: its reliability and influence affect how quickly and securely the network runs, how rewards are distributed, and how decision‑making power is concentrated—factors investors watch for risk, return and governance implications.
underwritten registered offering financial
"Closing of a $55 million underwritten registered offering to provide the Company with"
An underwritten registered offering is a public sale of a company’s securities that has been officially filed with regulators and is sold through one or more investment banks that agree to buy the securities and resell them to investors. Think of it like a store hiring a wholesaler who guarantees to buy the stock on the shelf so the store can raise cash immediately; for investors it signals structured distribution but can dilute existing shares and affect market price depending on size and demand.

AI-generated analysis. Not financial advice.

New NASDAQ Ticker Symbol "CNTN" to Begin Trading February 18, 2026

Company Positioned to Support Institutional Adoption of First Privacy-Enabled Public Blockchain Processing $9 Trillion in Monthly Transaction Volume

NEW YORK, Feb. 17, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ: THAR) (the "Company") the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize traditional financial markets, today announced the launch of a corporate rebrand in alignment with its digital asset treasury strategy. Effective Wednesday, February 18, 2026, the Company will change its name to Canton Strategic Holdings, Inc. In connection with the name change, the common stock of the Company will begin trading on NASDAQ under the ticker symbol "CNTN" prior to market open on February 18, 2026.

Established in November 2025 through a $545 million private placement, the Company executes a differentiated digital asset treasury strategy that seeks to drive value through initiatives including Canton Coin acquisition, operation of a Super Validator, and continued investment in applications that accelerate institutional utility and adoption of the Canton Network across capital markets. Canton Strategic Holdings remains the first and only publicly traded company supported by the Canton Foundation.

"Since launching our digital asset treasury strategy, we have continued to execute against a clear mandate to support institutional adoption of the Canton Network," said Mark Wendland, Chairman and CEO of the Company. "Our approval to operate a Super Validator on the Network, the expansion of institutional leadership on our Board of Directors, and our commitment to develop quarterly ecosystem reporting demonstrates our ability to strengthen the Canton ecosystem while delivering sustained value for shareholders."

Significant recent milestones for the Company include:

  • Securing approval as a Super Validator, aligned with a commitment to provide ecosystem reports on a quarterly basis.
  • Deepening institutional expertise on the Board of Directors, including recent appointments of Former CFTC Commissioner Jill Sommers and DRW Chief of Staff William Wiley.
  • Closing of a $55 million underwritten registered offering to provide the Company with additional growth capital for the continued expansion and development of its Canton-centric digital asset treasury strategy.

"From DTCC securing SEC consent for a pilot to tokenize U.S. Treasury securities, to global enterprises implementing onchain payroll, the utility of the Canton Network and its configurable privacy has quickly become the foundation for onchain financial rails," continued Mr. Wendland. "We are well-positioned to accelerate this modernization through our support of the Canton Network and strategic work to strengthen the ecosystem while driving value for shareholders."

No action is required from stockholders in connection with the change of the Company's corporate name or ticker symbol. 

About the Company

The Company (NASDAQ: THAR), is the first publicly traded company to leverage Canton Coin and support the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. In addition to driving value through activities on the Canton Network, the Company also operates clinical-stage biotech research and development. For more information, visit: www.cantonstrategic.com 

Cautionary Note Regarding Forward-Looking Statements

This press release contains statements that constitute "forward-looking statements" within the meaning of U.S. federal securities laws. Forward-looking statements are statements other than historical facts and include, without limitation, those regarding management expectations, strategy execution, market conditions, and the Company's involvement with the Canton Network. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Further information regarding factors that may affect the Company's prospects is included in its annual and quarterly reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov. The Company undertakes no obligation to update these statements except as required by law.

Canton is a registered trademark of Digital Asset (Switzerland) GmbH. Digital Asset is not affiliated with, and has not sponsored or endorsed, the operations of Canton Strategic Holdings, Inc.

Contacts

Media:
Gasthalter & Co.
(212) 257-4170
canton@gasthalter.com

Investors:
ir@cantonstrategic.com

X: @CantonStrategic
LinkedIn: Linkedin.com/CantonStrategicHoldings
Website: www.cantonstrategic.com 

Cision View original content:https://www.prnewswire.com/news-releases/tharimmune-inc-announces-corporate-rebrand-to-canton-strategic-holdings-inc-marking-milestone-in-canton-network-digital-asset-treasury-strategy-302689437.html

SOURCE Tharimmune, Inc.

FAQ

When will Tharimmune change its name and NASDAQ ticker to CNTN (THAR)?

The name change and ticker update take effect on February 18, 2026, before market open. According to the company, trading under CNTN will begin prior to market open on that date to reflect the rebrand.

What capital has Tharimmune raised to support the Canton digital asset treasury (THAR)?

The company raised a $545 million private placement and closed a $55 million registered offering. According to the company, these financings fund Canton Coin acquisition, validator operations, and ecosystem investments.

What does approval as a Super Validator mean for Canton Strategic Holdings (CNTN)?

Approval authorizes the company to operate a Super Validator on the Canton Network. According to the company, this enables participation in network consensus and supports institutional adoption efforts.

Who joined the board of Canton Strategic Holdings and why does it matter (CNTN)?

Former CFTC Commissioner Jill Sommers and DRW Chief of Staff William Wiley joined the board. According to the company, appointments deepen institutional expertise and governance for enterprise adoption initiatives.

Will shareholders need to take action for the name and ticker change to CNTN (THAR)?

No shareholder action is required for the corporate name or ticker symbol change. According to the company, the change is administrative and will occur automatically on February 18, 2026.

How will Canton Strategic Holdings report progress on its Canton Network strategy (CNTN)?

The company committed to provide quarterly ecosystem reporting on Canton Network activity and initiatives. According to the company, these reports aim to track treasury activity, validator operations, and ecosystem developments.
Tharimmune Inc

NASDAQ:THAR

THAR Rankings

THAR Latest News

THAR Latest SEC Filings

THAR Stock Data

177.09M
1.18M
Biotechnology
Pharmaceutical Preparations
Link
United States
BRIDGEWATER